• S.E. Combs
  • J. Debus


Das Bronchialkarzinom zeigt die weltweit die höchste altersstandardisierte Mortalitätsrate.Sie betrug im Jahre 2006 bei den Männern 53,7 pro 100000 Einwohner, bei den Frauen 18,1 pro 100.000 Einwohner. In Europa betrug die Inzidenz des Bronchialkarzinoms für Männer 60,8 pro 100.000 Einwohner, für Frauen 23,7 pro 100.000 Einwohner (Robert-Koch-Institut 2006). In den USA werden 222.500 Neuerkrankungen jährlich diagnostiziert, und 157.3000 Todesfälle sind auf Lungentumoren zurückzuführen (National Cancer Institute, 2010). Die kontinuierlich steigende Inzidenz bei Frauen geht mit einer leicht sinkenden Erkrankungshäufigkeit bei Männern einher.


  1. Ahamad A, Stevens CW, Smythe WR et al. (2003) Intensity- modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55:768–775PubMedGoogle Scholar
  2. Ahmad K, Fayos V, Kirsh M (1984) Apical lung carcinoma. Cancer 54:913–917PubMedGoogle Scholar
  3. Albain KS, Rusch VW, Crowley JJ et al. (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880–1892PubMedGoogle Scholar
  4. Andre F, Grunenwald D, Pujol JL et al. (2001) Patterns of relapse of N2 nonsmall cell lung carcinoma patients treated with preoperative chemotherapy-should prophylactic cranial irradiation be reconsidered? Cancer 91:2394–2400PubMedGoogle Scholar
  5. Anscher MS, Kong FM, Andrews K et al. (1998) Plasma transforming growth factor beta 1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41:1029–1035PubMedGoogle Scholar
  6. Arakawa A, Yasunaga T, Saitoh Y, Uozumi H, Takada C, Baba Y, Yoshizumi K, Takahashi M (1990) Radiation therapy of invasive thymoma. Int J Radiat Oncol Biol Phys 18(3):529–534PubMedGoogle Scholar
  7. Armstrong J, Raben A, Zelefsky M et al. (1997) Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 44:17–22PubMedGoogle Scholar
  8. Arriagada R, Kramer A, LeChevalier T et al. (1992) Competing events determing relapse-tree survival in limited small-cell lung carcinoma. J Clin Oncol 1.0:447–451Google Scholar
  9. Arriagada R, LeChevalier T, Rekacewicz E et al. (1997) Cisplatin-based chemoradiotherapy in patients with locally advanced non-small-cell lung cancer (NSCLC): Late analysis of a French randomized trial. Proc ASCO 16: 446 (abstract)Google Scholar
  10. Arriagada R, LeChevalier T, Ruffie P et al. (1990) Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center’s Lung Group. Int J Radiat Oncol Biol Phys 19: 1321–1324Google Scholar
  11. Auperin A, Arriagada R, Pignon JP et al. (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341:475–484Google Scholar
  12. Auperin A, Le Pechoux C, Rolland E et al. (2010). Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28(13):2181–90PubMedGoogle Scholar
  13. Baumann M, Herrmann T, Matthiessen W et al. (1997) CHARTWEL-Bronchus (ARO 97–1): a randomised multi-center trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-cell bronchial carcinoma. Strahlenther Onkol 173:663–667PubMedGoogle Scholar
  14. Baumann M, Herrmann T, Koch R, Matthiessen W, Appold S, Wahlers B, Kepka, Marschek G, Feltl D, Fietkau R, Budach W, Dunst J, Dziadziuszko R, Krause M, Zips D; CHARTWEL-Bronchus Studygroup (2011). Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). Radiother Oncol Jul;100(1):76-85. Epub 2011 Jul 13.Google Scholar
  15. Belderbos J, Uitterhoeve L, van Zandwijk N, Belderbos H, Rodrigus P, van de Vaart P, Price A, van Walree N, Legrand C, Dussenne S, Bartelink H, Giaccone G, Koning C; EORTC LCG and RT Group (2007). Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). Eur J Cancer 43(1):114–121Google Scholar
  16. Bentzen SM, Saunders M, Dische S et al. (2000) Updated data for CHART in NSCLC: further analyses. Radiother Oncol 55:86–87Google Scholar
  17. Bleehen NM, Girling DJ, Gregor A, Leonard RC, Machin D, McKenzie CG, Morgan DA, Smyth JF, Spittle MF, Stephens RJ et al. (1991) A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party. Br J Cancer 64(4):775–779PubMedGoogle Scholar
  18. Bleehen NM, Girling DJ, Machin D et al. (1992) A medical research council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCL) and poor performance Status. Br J Cancer 65:934–941Google Scholar
  19. Bleehen NM, Girling DJ, Machin D, Stephens RJ (1993) A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party. Br J Cancer 68(6):1150–1156PubMedGoogle Scholar
  20. Brodin O, Nou E, Mercke C, Linden CJ, Lundstrom R, Arwidi A, Brink J, Ringborg U (1996) Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. Eur J Cancer 32A(11):1893–1900PubMedGoogle Scholar
  21. J. D. Bradley, R. Paulus, R. Komaki, G. Masters, K. Forster, S. E. Schild, J. A. Bogart, Y. I. Garces, S. Narayan, H. Choy (2011). A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-dose (74 Gy) Conformal Chemoradiotherapy +/- Cetuximab for Stage IIIA/IIIB Non-Small Cell Lung Cancer: Preliminary Findings on Radiation Dose in RTOG 0617. Abstract Annual Meeting ASTRO 2011, Miami, Florida.Google Scholar
  22. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, et al. (1999) Proton-beam radiotherapy for early-stage lung cancer. Chest 116:1313–1319PubMedGoogle Scholar
  23. Bush DA, Slater JD, Shin BB, Cheek G, Miller DW, Slater JM (2004). Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126:1198–1203PubMedGoogle Scholar
  24. Bush DA, Do SY, Slater JD (2010). Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy. J Oncol 2010:251208Google Scholar
  25. Byhardt RW, Pajak TF, Emami B et al. (1993) A phase I/II study to evaluate accelerated fractionation via concomittant boost for squamous, adeno, and large cell carcinoma of the lung: re-port of Radiation Oncology Group 84–07. Int J Radiat Oncol Biol Phys 26:459–468PubMedGoogle Scholar
  26. Carmack E (1994) Surgical treatment of small cell lung cancer. Lung Cancer 11, Suppl 2:228Google Scholar
  27. Carmichael J, Degraff WG, Gamson J et al. (1989). Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 25:527–534PubMedGoogle Scholar
  28. Carney DN (1999) Prophylactic cranial irradiation and small cell lung cancer. N Engl J Med 341:524–526PubMedGoogle Scholar
  29. Catarino PA, Goldstraw P (2006). The future in diagnosis and staging of lung cancer: surgical techniques. Respiration 73:717–732PubMedGoogle Scholar
  30. Cerfolio RJ, Ojha B, Bryant AS et al. (2004). The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lungs cancer. Ann Thorac Surg 78:1017–1023PubMedGoogle Scholar
  31. Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD (2011) Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011 Aug 1;80(5):1350–1357PubMedGoogle Scholar
  32. Choi NC, Carey RW, Daly W et al. (1997) Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15:712–722PubMedGoogle Scholar
  33. Chung CK, Stryker JA, O’Neil M et al. (1982) Evaluation of adjuvant postoperative radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 8:1877–1880PubMedGoogle Scholar
  34. Clamon G, Herndon J, Cooper R et al. (1999) Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Co-operative Oncology Group. J Clin Oncol 17:4–11PubMedGoogle Scholar
  35. Cox JD, Azarnia N, Byhardt RW et al. (1990) A randomized phase 1/11 trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with >69.6 Gy in favorable patients with Radiation Therapy Oncology group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8:1543–1555PubMedGoogle Scholar
  36. Coy P, Hodson DI, Murray N et al. (1993) Pattern of failure following loco-regional radiotherapy of limited stage small cell lung cancer. Int J Radial Oncol Biol Phys 28:355–362Google Scholar
  37. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd (1988) Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6(11):1722–1727PubMedGoogle Scholar
  38. Curran WJ Jr (2003) Evolving chemoradiation treatment strategies for locally advanced non-small-cell lung cancer. Oncology (Williston Park). 17(12 Suppl 13):7–14Google Scholar
  39. Dartevelle PG, Chapelier AR, Macchiarini P et al. (1993) Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 105:1025–1034PubMedGoogle Scholar
  40. Depierrre A, Millerron B, Moro D et al. (1999) Phase III trial of neoadjuvant chemotherapy in resectable stage I (except T1NO), II, IIIa non-small cell lung cancer: the French experience. Proc ASCO 18:1792 (abstract)Google Scholar
  41. De Ruysscher D, Vansteenkiste J (2000) Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol 55(1):1–9PubMedGoogle Scholar
  42. Deslauriers J, Gregoire J (2000) Clinical and surgical staging of non-small cell lung cancer. Chest 117:96S–103SPubMedGoogle Scholar
  43. Detterbeck FC, Jantz MA, Wallace M et al. (2007). Invasive mediastinal staging of lung cancer : ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:2025–2205Google Scholar
  44. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd, Green MR (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323(14):940–945PubMedGoogle Scholar
  45. Dillman RO, Herndon J, Seagren SL et al. (1996) Improved survival of stage III non-small cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Nat Cancer Inst 88:1210–1215PubMedGoogle Scholar
  46. Dosoretz D, Galmarini D, Rubenstein JH et al. (1993) Local control in medically inoperable lung cancer: analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 27:507–516PubMedGoogle Scholar
  47. Douillard JY, Rosell R, De Lena M et al. (2006). Adjuvant vinorelbine plus cisplatin versus observation in patiens with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association, ANITA) – a randomized controlled trial. Lancet Oncol 7(9):719–727PubMedGoogle Scholar
  48. Eberhardt W, Wilke H, Stamatis G et al. (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16:622–634PubMedGoogle Scholar
  49. Firat S, Pleister A, Byhardt RW, Gore E (2006) Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). Am J Clin Oncol Jun;29(3):252–257Google Scholar
  50. Forquer JA, Rong N, Fakiris AJ, Loehrer PJ SR; Johnstone PA (2010). Postoperative radiotherapy after surgical resection ofl nt J Radiat Oncol Biol Phys ofInt J Feb 1;76(2):440–445. Epub 2009 May 8. thymoma: differing roles in localized and regional diseaseGoogle Scholar
  51. Forniasiero A, Daniele O, Ghiotto C et al. (1991) Chemotherapy for invasive thymoma: a 13 year experience. Cancer 68:30–33Google Scholar
  52. Fournel P, Robinet G, Thomas P, Souquet PJ, Léna H, Vergnenégre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daurés JP, Mornex F, Pérol M; Groupe Lyon-Saint-Etienne d’Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie (2005). Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d’Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. J Clin Oncol.23(25):5910–5917Google Scholar
  53. Frytak S, Shaw JN, O’Neill BP, Lee RE, Eagan RT, Shaw EG, Richardson RL, Coles DT, Jett JR (1989) Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol 12(1):27–33PubMedGoogle Scholar
  54. Furuse K, Fukuoka M, Kawahara M et al. (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with Mitomycin, Vindesine and Cisplatin in unresectable stage 111 non-small-cell lung cancer. J Clin Oncol 17:2692–2699PubMedGoogle Scholar
  55. Gandara DR, Edelman M, Lara P, Roberts P, Leigh B (2000) Evolution of combined modality therapy for stage III non-small-cell lung cancer. Oncology (Williston Park) 14(7 Suppl 5):35–41Google Scholar
  56. Giaccone G, Ardizzoni A, Kirkpatrick A et al. (1996) Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14:814–820PubMedGoogle Scholar
  57. Ginsberg RJ (1993) Multimodality therapy for stage IIIA (N2) lung cancer. An overview. Chest 103(4 Suppl):356S–359S (review)PubMedGoogle Scholar
  58. Goeckenjahn G, Sitter H, Thomas M et al. (2010), Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Interdisziplinäre S3 Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Krebsgesellschaft (DKG). Pneumologie (64): Suppl. e1-e164Google Scholar
  59. Gore EM, Bae K, Wong SJ et al. (2010) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer:primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncoll.Jan 20;29(3):272–278Google Scholar
  60. Graham MV, Purdy JA, Emami BE et al. (1999) Clinical dose volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323–329PubMedGoogle Scholar
  61. Griffeth LK, Rich KM, Dehdashti R et al. (1993). Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology 186:37–44PubMedGoogle Scholar
  62. Gregor A (1994) Factors influencing use of alternating chemotherapy and radiation schedules in small cell lung cancer. Lung Cancer 10(Suppl 1):S299–305 (review)PubMedGoogle Scholar
  63. Grunenwald D, Andre F, LePechoux C et al. (2001) Benefit of surgery after chemoradiotherapy in stage 1I1B (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 122:796–802PubMedGoogle Scholar
  64. Guckenberger M, Meyer J, Wilbert J, Richter A, Baier K, Mueller G, Flentje M (2007). Intra-Fractional undertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 83(1):57–64PubMedGoogle Scholar
  65. Guckenberger M, Richter A, Wilbert J, Flentje M, Partridge M (2011). Adaptive Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Does Not Underdose the Microscopic Disease and has the Potential to Increase Tumor Control.Int J Radiat Oncol Biol Phys. 15;81(4):e275-82. Epub 2011 Apr 15Google Scholar
  66. Guckenberger M, Wilbert J, Richter A, Baier K, Flentje M. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):901-8. Epub 2010 Aug 12Google Scholar
  67. Gupta V, Krug LM, Laser B et al. (2009). Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy. J Thorax Oncol 4(6):746–50Google Scholar
  68. Halpern BS, Schiepes C, Weber WA et al. (2005). Presurgical stating of non-small cell lung cancer: postiron emission tomography, integrated positon emission tomography/CT, and software image fusion. Chest 128:2289–2297PubMedGoogle Scholar
  69. Haniuda M, Miyazawa M, Yoshida K et al. (1996) Is postoperative radiotherapy for thymoma effective? Ann Surg 224:219–224PubMedGoogle Scholar
  70. Harms W, Schraube P, Becker H et al. (2001) Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlenther Onkol 176(2):60–66Google Scholar
  71. Hauswald H, Stoiber E, Rochet N et al., (2010). Treatment of recurrent bronchial carcinoma: The role of high-dose-rate endolumninal brachytherapy. Int J Radiat Oncol Biol Phys 77(2):373–377PubMedGoogle Scholar
  72. Hilaris BS, Martini N, Wong GyEt al. (1987) Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 67:965–977PubMedGoogle Scholar
  73. Hof H, Herfarth KK, Munter M et al. (2003) Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:335–341PubMedGoogle Scholar
  74. Hof H, Zgoda J, Nill S, Hoess A, Kopp-Schneider A, Herfarth K, Debus J, Plathow C (2010). Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. Aug 1;77(5):1369–1374Google Scholar
  75. Hsu HC, Huang EY, Wang CJ, Sun LM, Chen HC (2002) Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 52(3):801–805PubMedGoogle Scholar
  76. Hughes JMB (1996) 18F-Fluorodeoxyglucose PET scans in lung cancer. Thorax 51 (Suppl 2):16–22Google Scholar
  77. Jeremic B, Shibamoto Y, Acimovic L et al. (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 15:893–900PubMedGoogle Scholar
  78. Jeremic B, Shibamoto Y, Nikolic N et al. (1999) Role of radiation therapy in the combined-modality treatment of patients with extensive-disease small cell lung cancer: a randomized study. J Clin Oncol 17:2092—2099PubMedGoogle Scholar
  79. Jöckel KH, Ahrens W, Jahn I, Pohlabeln H, Bolm-Audorff U (1995) Untersuchungen zu Lungenkrebs und Risiken am Arbeitsplatz. Schriftenreihe der Bundesanstalt für Arbeitsmedizin, BremerhavenGoogle Scholar
  80. Johnson DH, Einhorn LH, Bartolucci A, Birch R, Omura G, Perez CA, Greco FA (1990) Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 113(1):33–38PubMedGoogle Scholar
  81. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C (1993) Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27(3):517–523PubMedGoogle Scholar
  82. Kelly K, Crowley J, Bunn PA et al. (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group Trial. J Clin Oncol 19:3210–3218PubMedGoogle Scholar
  83. Kies MS, Mira JG, Crowley JJ et al. (1987) Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study. J Clin Oncol 5:592–600PubMedGoogle Scholar
  84. Komaki R, Mountain CF, Holbert JM et al. (1990) Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (MO) at presentation. Int J Radiat Oncol Biol Phys 19:31–36PubMedGoogle Scholar
  85. Kristjansen PE, Kristensen CA (1993) The role of prophylactic cranial irradiation in the management of small cell lung cancer. Cancer Treat Rev 19(1):3–16PubMedGoogle Scholar
  86. Kwa S, Lebesque J, Theuws J et al. (1998) Radiation pneumonitis as a function of mean dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42:1–9PubMedGoogle Scholar
  87. Lambert PM (1978) Radiation myelopathy of the thoracic spinal cord in long term survivors treated with radical radio-therapy using conventional fractionation. Cancer 41:1751–1760PubMedGoogle Scholar
  88. Langer CJ, Hsu C, Curran W et al. (2001) Do elderly patients with locally advanced non-small cell lung cancer (NSCLC) benefit from combined modality therapy? A secondary anal-ysis of RTOG 94–10. Int J Radiat Oncol Biol Phys 51(Suppl 1):31 (abstract)Google Scholar
  89. Lardinois D, Weder W, Hany TF et al. (2003). Staging of non-small-cell lung cancer with integrated postiron-emission tomography and computed tomography. N Engl. J Med 348: 2500–-250Google Scholar
  90. LeChevalier T, Arriagada R, Ouoix E et al. (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Nat Cancer Inst 83: 417–423Google Scholar
  91. Le Pechoux (2011). Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist. 2011;16(5):672–681PubMedGoogle Scholar
  92. Liao Z, Lin SH, Cox JD (2011). Status of particle therapy for lung cancer. Acta Oncol 50: 745–756PubMedGoogle Scholar
  93. Liengsgwangwong V, Bonner JA, Shaw EG et al. (1994) Limited-stage small-cell lung cander: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 12:496–502Google Scholar
  94. Livingston RB, Schulman S, Mira JG et al. (1986) Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology study. Cancer Treat Rep 70:1395–1401PubMedGoogle Scholar
  95. Lloyd C, Silvestri GA (2001) Mediastinal staging of non-small-cell lung cancer. Cancer Control 8:311–317PubMedGoogle Scholar
  96. Loehrer PJ, Kim KM, Aisner SC et al. (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol 12:1164–1168PubMedGoogle Scholar
  97. Lung Cancer (2009) Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.Sep;65(3) 333–338.doi:10.1016/j.lungcan.200812004.Epub 2009 Jan 13Google Scholar
  98. Macchiarini P, Chella A, Ducci F et al. (1991) Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68:706–713PubMedGoogle Scholar
  99. Mac Manus MP, Hicks RJ, Matthews JP et al. (2001). High rate of detection of unsuspected distanct metastases be PET in apparent stage III non-small cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50:287–293Google Scholar
  100. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E (1991) Thymoma: results of 241 operated cases. Ann Thorac Surg 51(1):152–156PubMedGoogle Scholar
  101. Maggi G, Casadio C, Pischedda F et al. (1994) Combined radiosurgical treatment of Pancoast tumor. Ann Thorac Surg 57:198–202PubMedGoogle Scholar
  102. Marino P, Preatoni A, Cantoni A (1995) Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small-cell lung cancer. Cancer 76:593–601PubMedGoogle Scholar
  103. Marks L, Munley MT, Bentel GC et al. (1997) Physical and biological predictors of changes in whole lung function following thoracic irradiation. Int J Radial Oncol Biol Phys 39:563–570Google Scholar
  104. Martel MK, Ten Haken RK, Hazuka MB et al. (1994) Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28:575–581PubMedGoogle Scholar
  105. Martini N, Flehinger BJ (1987) The role of surgery in N2 lung cancer. Surg Clin North Am 67:1037–1049PubMedGoogle Scholar
  106. Masaoka A, Monden Y, Nakahara K et al. (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492PubMedGoogle Scholar
  107. Mayor S. (2005). NICE issues guidance for diagnosis and treatment of lung cancer. BMJ 330:439PubMedGoogle Scholar
  108. Menzler S, Schaffrath Rosario A, Wichmann HE et al. (2006) Abschätzung des attibutablen Lungekrebsrisikos in Deutschland durch Radon in Wohnung. In: Wichmann HE, Schlipköter HW Fülgraff G, Hrsg. Fortschritte der Umweltmedizin. Landsberg: ecomed Medizin.Google Scholar
  109. Millar J, Ball D, Worotniuk V et al. (1996) Radiation treatment of superior sulcus lung carcinoma. Australas Radiol 40: 55–60PubMedGoogle Scholar
  110. Miller JI, Phillips TW (1990) Neodymium YAG laser and brachy therapy in the management of inoperable bronchogenic carcinoma. Ann Thorac Surg 50:190–196PubMedGoogle Scholar
  111. Monden Y, Nakahara K, Iioka S et al. (1985) Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39(2):165–169PubMedGoogle Scholar
  112. Mornex F, Resbeut M, Richaud P et al. (1995) Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. Int J Radiat Oncol Biol Phys 32:651–659PubMedGoogle Scholar
  113. Movsas B, Raffin TA, Epstein AH et al. (1997) Pulmonary radiation injury. Chest 111:1061–1076PubMedGoogle Scholar
  114. Münter MW, Nill S, Thilmann C et al. (2003). Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results. Strahlenther Onkol 179: 535–541PubMedGoogle Scholar
  115. Murray N, Coy R, Pater JL et al. (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336–344PubMedGoogle Scholar
  116. Naruke T, Goya T, Tsuchiya R et al. (1988) The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 46:603–610PubMedGoogle Scholar
  117. National Institue for Clinical Excellence (NICE), National Collaborating Center for Acute Care (2005). Diagnosis and treatment of lung cancer. London: Zugegriffen:16. März 2013
  118. Nicolson M, Gilligan D, Smith I et al. (2007). Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): First results of the MRC LU22/NVALT/EORTC 08012 multi-centre randomized trial. J Clin Oncol 25:7518Google Scholar
  119. Olsen GN, Block AJ, Senwon EW et al. (1975). Pulmonary function evaluation of the lung resection candidate: aaprospective study. Am Rev Resir Dis 111 379–387Google Scholar
  120. Omenn GS, Merchant J, Boatman E et al. (1986). Contribution of environmental fibers to respiratory cancer. Environ Health Perspect. 70:51–56PubMedGoogle Scholar
  121. Ordonez NG. (2005) Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med 129:1407–1414PubMedGoogle Scholar
  122. O’Rourke N, Roque I Figuls M, Farre Bernado N et al. (2010) Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrange Database Syst Rev. 16(6):CD002140Google Scholar
  123. Oxford Centre for Evidence-based Medicine (CEBM). Levels of evidende. Oxford: 2001.
  124. Palm L, Hellwig D, Leutz M et al. (1999). Diagnostische Aussagekraft der Positronen-Emissions-Tomographie (PET) bei cerebrealen Metastasen von Bronchialkarzinoman. Med. Klin (Munich) 94:224–227Google Scholar
  125. Payne DG (1988) Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy? J Clin Oncol 6(3):552–558PubMedGoogle Scholar
  126. Pedersen AG, Kristjansen PE, Hansen HH (1988) Prophylactic cranial irradiation and small cell lung cancer. Cancer Treat Rev 15(2):85–103)PubMedGoogle Scholar
  127. Perez CA, Stanley K, Rubin P et al. (1980a) Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 6:987–994Google Scholar
  128. Perez CA, Stanley K, Rubin P et al. (1980b) A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Cancer 45:2744–2753Google Scholar
  129. Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C et al. (1987) Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 316(15):912–918PubMedGoogle Scholar
  130. Pisters K, Vallieres E, Bunn P et al. (2007). Surgery alone or surgery plus induction paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC). Folow-up on a phase III trial. J Clin Oncol 25:7520Google Scholar
  131. PORT Meta-Analysis Trialists Group (2005). Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev. 2005;(1):CD002142Google Scholar
  132. Rea F, Sartori F, Loy M et al. (1993) Chemotherapy and operation for invasive thymoma. J Thorac Carciovasc Surg 106:543–549Google Scholar
  133. Ricci C, Rendina EA, Venuta F (1989) Superior pulmonary sulcus tumors: radical resection and palliative treatment. Int Surg 74:175–179PubMedGoogle Scholar
  134. Rietzel E, Bert C (2010). Respiratory motion management in particle therapy .Med Phys. 2010 Feb;37(2):44960Google Scholar
  135. Rosenthal CJ, Wampler GL, Brereton HD, Ahlgren JD, Lokich JJ, Fryer JG, Alt DE (1992) A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer. A Mid-Atlantic Oncology Program study. Am J Clin Oncol 15(1):12–17PubMedGoogle Scholar
  136. Rosenthal SA, Curran WJ, Herbert SH et al. (1992) Clinical stage II non-small cell lung cancer treated with radiation therapy alone. Cancer 70:2410–2417PubMedGoogle Scholar
  137. Rosenzweig KE, Sim SE, Mychalczak B et al. (2001) Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50:681–685PubMedGoogle Scholar
  138. Roth JA, Atkinson EN, Fossella F et al. (1998) Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III. A non-small-cell lung cancer. Lung Cancer 21:1–6PubMedGoogle Scholar
  139. Rowell NP, O’Rourke NP (2004) Concurrent chemoradiotherapy. NSCLC Cochrane databases syst rev 18Google Scholar
  140. Rubin P, Shapiro DL, Finklestein JN, Penney DP (1980) The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys 6(1):75–77PubMedGoogle Scholar
  141. Rusch VW, Klimstra DS, Venkatraman ES (1996) Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 62:798–810PubMedGoogle Scholar
  142. Rusch VW, Giroux DJ, Kraut MJ et al. (2001) Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 121:472–183PubMedGoogle Scholar
  143. Sandler HM, Curran WJ, Turrisi AT (1990) The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung lung cancer. Int J Radiat Oncol Biol Phys 10:9–13Google Scholar
  144. Saunders M, Dische S, Barrett A et al. (1999) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicenter trial. Radiother Oncol 52:137–148PubMedGoogle Scholar
  145. Sause W, Kolesar R, Taylor S et al. (2000) Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117:358–364PubMedGoogle Scholar
  146. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Shaw EG, Marks RS, Frytak S, Lange CM, Li H (1997) The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 80(8):1399–1408PubMedGoogle Scholar
  147. Schaake-Koning C, van den Bogaert W, Dalesio O et al. (1992) Effects of concomittant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524–530PubMedGoogle Scholar
  148. Schiller JH, Harrington D, Belani C et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92–98PubMedGoogle Scholar
  149. Schraube P, von Kampen M, Oetzel D et al. (1995) The impact of 3-D radiotherapy planning after a pneumonectomy compared to a conventional treatment set-up. Radiother Oncol 37:65–70PubMedGoogle Scholar
  150. Schraube R, Latz D (1993) Wertigkeit der Strahlentherapie bei der Behandlung des Pancoast-Tumors der Lunge. Strahlenther Onkol 169:265–269PubMedGoogle Scholar
  151. Seppenwoolde Y, Lebesque .JV (2001) Partial Irradiation of the lung. Semin Radiol Oncol 11:247–258Google Scholar
  152. Shaw RR (1984) Pancoast’s tumor. Ann Thorac Surg 37(4):343–345PubMedGoogle Scholar
  153. Shin DM, Walsh GL, Komaki R et al. (1998) A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129:100–104PubMedGoogle Scholar
  154. Simon G, Ginsberg RJ, Ruckdeschel JC (2001) Small-cell lung cancer. Chest Surg Clin N Am 11(1):165–188 ix (review)PubMedGoogle Scholar
  155. Slotman BJ; Mauer ME, Bottomley A et al. (2009). Prophylactic Cranial Irradiation in Extensive DiseaseGoogle Scholar
  156. Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups. Journal of Clinical Oncology 27:78–84Google Scholar
  157. Slotman BJ, Faivre-Finn C, Kramer G Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S (2007) EORTC Radiation Oncology Group and Lung Cancer Group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664–672 : Zugegriffen: 24. Juni 2013Google Scholar
  158. Socinski MA, Rosenman JG, Halle J et al. (2001) Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage I1IA/B nonsmall cell lung carcinoma – a modified phase I/II trial. Cancer 92:1213–1223PubMedGoogle Scholar
  159. Song JW, Oh YM, Shim TS, Kim WS, Ryu JS, Choi CM. (2009) Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Lung Cancer Sep;65(3):333–8. doi: 10.1016/j.lungcan.2008.12.004. Epub 2009 Jan 13.Google Scholar
  160. Stewart JR, Fajardo LF, Gillette SM et al. (1995) Radiation injury to the heart. Int J Radiat Oncol Biol Phys 31:1205–1211PubMedGoogle Scholar
  161. Stinchcombe TE, Hodgson L, Herndon JE et al. (2009). Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer. J Thorac Oncol 4(9):1117↑1125Google Scholar
  162. SSK Strahlenschutzkommission. (2009) Empfehlung zum Einfluss der natürlichen Strahlenexposition auf die Krebsentstehung.Google Scholar
  163. Stuschke M, Eberhardt W, Pöttgen C et al. (1999) Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychological effects. J Clin Oncol 17:2700–2709PubMedGoogle Scholar
  164. Sun A, Bae K, Gore EM et al. (2011) Pase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer:neurocognitive and quality-of-life analysis. J Clin Oncol. Jan 20; 29(3):279–286Google Scholar
  165. Sundaresan N, Galicich JH, Lane JM, Bains MS, McCormack P (1985) Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization. J Neurosurg 63(5):676–684PubMedGoogle Scholar
  166. Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: state of the art. J Clin Oncol 17(7):2280–2289PubMedGoogle Scholar
  167. Thomas M, Gatzemeier U, Goerg R, Matthiessen W, Morr H, Schonfeld N, Ukena D, Stamatis G (2000) [Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society]. Pneumologie 54(8):361–371PubMedGoogle Scholar
  168. Travis EL, Harley RA, Fenn JO, Klobukowski CJ, Hargrove HB (1977) Pathologic changes in the lung following single and multi-fraction irradiation. Int J Radiat Oncol Biol Phys 2(5/6):475–490PubMedGoogle Scholar
  169. Trodella L, Granone P, Valente S, Valentini V, Balducci M, Mantini G, Turriziani A, Margaritora S, Cesario A, Ramella S, Corbo GM, D’Angelillo RM, Fontana A, Galetta D, Cellini N (2002) Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 62(1):11–19PubMedGoogle Scholar
  170. Turrisi AT, Glover DJ, Mason BA (1988) Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report. Antibiot Chemother 41:109–114PubMedGoogle Scholar
  171. Turrisi AT 3rd, Glover DJ (1990) Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease. Int J Radiat Oncol Biol Phys 19(6):1473–1479Google Scholar
  172. Turrisi AT 3rd (1997) Concurrent chemoradiotherapy for limited small-cell lung cancer. Oncology (Williston Park) 11(9 Suppl 9):31–37Google Scholar
  173. Turrisi AT 3rd, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, Wagner H, Aisner S, Johnson DH (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340(4):265–271PubMedGoogle Scholar
  174. Turrisi AT 3rd (2000) Prophylactic cranial irradiation in small-cell lung cancer: is it still controversial or is it a no-brainer? Oncologist 5(4):299–301PubMedGoogle Scholar
  175. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C (1990) Role of radiation therapy in locally advanced thymoma. Radiother Oncol 19(3):273–280PubMedGoogle Scholar
  176. Vokes EE, Herndon JE 2nd, Crawford J et al. (2002) Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 15:4191–4198Google Scholar
  177. Vokes EE, Herndon JE, Kelley MJ et al. (2007). Induction Chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alond for regionally advanced unresectable stage III non-small cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25(13):1698–704PubMedGoogle Scholar
  178. Weber WA, Dietlein M, Hellwig D et al. (2003). PET with (18)-F-Fluorosdeoxyglucose for staging of non-small cell lung cancer. Nuklearmadizin 42:135–144Google Scholar
  179. Weisenburger TH (1994) Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. LCSG 773. Chest 106(6 Suppl): 297S–301SPubMedGoogle Scholar
  180. Williams C, Alexander M, Glatstein EJ, Daniels JR (1977) Role of radiation therapy in combination with chemotherapy in extensive oat cell cancer of the lung: a randomized study. Cancer Treat Rep 61(8):1427–1431PubMedGoogle Scholar
  181. Willner J, Baier K, Caragiani E et al. (2002) Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52: 382–389PubMedGoogle Scholar
  182. Wilson HE, Stanley K, Vincent RG, Mountain CF, Sealy R, Cohen M, Chen TY, Batley F, Kilman J, Kakos G, Vasko J, Williams TE, Tucker RD (1983) Comparison of chemotherapy alone versus chemotherapy and radiation therapy of extensive small cell carcinoma of the lung. J Surg Oncol 23(3):181–184PubMedGoogle Scholar
  183. World Health Organization Classification of Tumours. Pathology and Genetics of the Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Muller-Hermelink HI, Harros CC. Hrsg. Lyon: IARC Press 2004:9–124Google Scholar
  184. Wurschmidt F, Bunemann H, Bunemann C, Beck-Bornholdt HP, Heilmann HP (1994) [The radiotherapy of inoperable non-small-cell bronchial carcinoma. A retrospective analysis of 427 cases]. Strahlenther Onkol 170(5):302–304PubMedGoogle Scholar
  185. Wurschmidt F, Bunemann H, Bunemann C, Beck-Bornholdt HP, Heilmann HP (1994) Inoperable non-small cell lung cancer: a retrospective analysis of 427 patients treated with high-dose radiotherapy. Int J Radiat Oncol Biol Phys 28(3):583–588PubMedGoogle Scholar
  186. Zhang HX, Yin WB, Zhang LJ, Yang ZY, Zhang ZX, Wang M, Chen DF, Gu XZ (1989) Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14(2): 9–94Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • S.E. Combs
    • 1
  • J. Debus
    • 1
  1. 1.Abteilung für Radioonkologie und StrahlentherapieRadiologische KlinikHeidelbergDeutschland

Personalised recommendations